Evaluation of Complication Rates after Breast Surgery Using Acellular Dermal Matrix: Median Follow-Up of Three Years

Table 1

Patient collective with ADM-implementation.

ADM	Product	Number of ADM implants used	Number of treated patients	Avg. patient age (years)	Avg. follow-up time (months)
HADM	Epiflex/DIZG	15	12	46 (36–76)	40 (20–50)
PADM	Strattice/LifeCell	21	16	56 (44–66)	43 (30–54)
BADM	Tutomesh/RTI Surgical	16	13	53 (33–74)	20 (12–31)
Total	All ADMs	52	41	52 (33–76)	36 (12–54)

Listing of matrix, name of ADM-product and its fabricant, amount of breast reconstructions (BR)/augmentations with usage of ADMs, number of patients treated with ADMs, average patient age and range in years, and average follow-up time + range in months of the given patient collective, which received a breast reconstruction with ADM; HADM: human ADM, PADM: porcine ADM, and BADM: bovine ADM.